Drug Type Stem cell therapy |
Synonyms- |
Target |
Action modulators |
Mechanism CTGF modulators(Connective tissue growth factor modulators), NF-κB modulators(Nuclear factor NF-kappa-B complex modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophy, Duchenne | Preclinical | United States | 30 Nov 2022 |